OTCM
TLCC
Market cap129kUSD
May 27, Last price
0.00USD
Name
Twinlab Consolidated Holdings Inc
Chart & Performance
P/E
—
P/S
0.01
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-0.58%
Rev. gr., 5y
-28.58%
Revenues
14m
-74.10%
Net income
-14m
L+66.80%
CFO
3m
P
Earnings
Jul 29, 2025
Profile
Twinlab Consolidated Holdings, Inc., together with its subsidiaries, manufactures, markets, distributes, and retails nutritional supplements and other natural products in the United States and internationally. The company offers vitamins, minerals, resveratrol, collagen, keratin, specialty supplements, and sports nutrition products under the Twinlab brand; healthy aging and beauty products under the Reserveage Nutrition and ResVitale brands; diet and energy products under the Metabolife; and a line of herbal teas under the Alvita brand. It also acts as contract manufacturer for private label customers. The company sells its products in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, stick packs, sprays, and powders primarily through health and natural food stores, supermarkets, mass market retailers, specialty stores retailers, online retailers, and websites. Twinlab Consolidated Holdings, Inc. was founded in 2013 and is based in Boca Raton, Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | 13,617 -74.10% | 52,584 -27.06% | |||||||
Cost of revenue | 15,006 | 54,215 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (1,389) | (1,631) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | 43 | 25 | |||||||
Tax Rate | |||||||||
NOPAT | (1,432) | (1,656) | |||||||
Net income | (13,714) 66.80% | (8,222) -44.97% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 96,489 | 98,540 | |||||||
Long-term debt | 5,820 | 9,235 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | 102,290 | 106,877 | |||||||
| Cash flow | |||||||||
Cash from operating activities | 2,897 | (4,311) | |||||||
CAPEX | (99) | ||||||||
Cash from investing activities | (99) | ||||||||
Cash from financing activities | (3,744) | 1,647 | |||||||
FCF | 16,163 | 7,176 | |||||||
| Balance | |||||||||
Cash | 19 | 868 | |||||||
Long term investments | 30 | ||||||||
Excess cash | |||||||||
Stockholders' equity | (369,744) | (356,000) | |||||||
Invested Capital | 329,405 | 333,267 | |||||||
ROIC | |||||||||
ROCE | 3.44% | 7.17% | |||||||
| EV | |||||||||
Common stock shares outstanding | 259,093 | 259,093 | |||||||
Price | 0.04 | ||||||||
Market cap | 9,846 | ||||||||
EV | 112,136 | ||||||||
EBITDA | (731) | (522) | |||||||
EV/EBITDA | |||||||||
Interest | 8,271 | 7,902 | |||||||
Interest/NOPBT | |||||||||